Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-04

Clinical Trial Update: Use of Ulipristal Acetate in Induction of Second Trimester Missed Abortion [Phase 4]

View source ↗

Summary

Phase 4 trial update on using ulipristal acetate to induce second-trimester abortion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ulipristal acetate (ulipristal acetate)

Snippet

Sponsor: Ain Shams University | Conditions: Induction of Second Trimester Abortion | Phase 4 | Status: COMPLETED